Lake Street Maintains Buy on Insight Molecular, Lowers Price Target to $9

Benzinga · 2d ago
Lake Street analyst Thomas Flaten maintains Insight Molecular (NASDAQ:IMDX) with a Buy and lowers the price target from $12 to $9.